Emma Lees

15.3k total citations · 4 hit papers
73 papers, 9.8k citations indexed

About

Emma Lees is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Emma Lees has authored 73 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 30 papers in Oncology and 14 papers in Cell Biology. Recurrent topics in Emma Lees's work include Cancer-related Molecular Pathways (26 papers), Microtubule and mitosis dynamics (14 papers) and Genomics and Chromatin Dynamics (10 papers). Emma Lees is often cited by papers focused on Cancer-related Molecular Pathways (26 papers), Microtubule and mitosis dynamics (14 papers) and Genomics and Chromatin Dynamics (10 papers). Emma Lees collaborates with scholars based in United States, United Kingdom and France. Emma Lees's co-authors include Vjekoslav Dulić, Shawna C. O. Reed, David Parry, Steven I. Reed, E Harlow, Wolfgang Seghezzi, J. Wade Harper, William K. Kaufmann, Stephen J. Elledge and Barbara Faha and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Emma Lees

70 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest

1994 1.3k citations Emma Lees, Steven I. Reed et al. profile →
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

1994 835 citations Emma Lees et al. Nature profile →
Association of human cyclin E with a periodic G1-S phase protein kinase

1992 767 citations Emma Lees et al. profile →
Raf-Induced Proliferation or Cell Cycle Arrest Is Determined by the Level of Raf Activity with Arrest Mediated by p21^Cip1

1997 578 citations David Parry, Emma Lees et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma Lees United States	46	7.2k	4.9k	1.8k	1.1k	977	73	9.8k
Jean Y. J. Wang United States	56	8.3k 1.2×	4.5k 0.9×	1.4k 0.8×	1.2k 1.1×	886 0.9×	127	11.6k
James M. Roberts United States	40	7.2k 1.0×	4.8k 1.0×	2.2k 1.2×	1.0k 1.0×	1.1k 1.1×	52	9.6k
Richard A. Ashmun United States	30	5.9k 0.8×	4.5k 0.9×	1.0k 0.6×	917 0.8×	811 0.8×	53	8.4k
Ada Sacchi Italy	55	5.8k 0.8×	3.7k 0.7×	1.2k 0.7×	1.5k 1.4×	612 0.6×	162	8.4k
Todd Waldman United States	39	8.0k 1.1×	5.7k 1.2×	1.2k 0.7×	2.0k 1.8×	696 0.7×	66	10.9k
Bruce E. Clurman United States	45	7.8k 1.1×	4.2k 0.9×	1.9k 1.0×	1.2k 1.1×	722 0.7×	77	9.6k
Khandan Keyomarsi United States	51	6.7k 0.9×	5.5k 1.1×	1.7k 1.0×	2.2k 2.0×	955 1.0×	158	10.7k
Vjekoslav Dulić France	28	5.5k 0.8×	4.2k 0.8×	1.4k 0.8×	886 0.8×	588 0.6×	41	7.7k
Phang‐Lang Chen United States	53	9.2k 1.3×	4.5k 0.9×	1.6k 0.9×	1.4k 1.3×	3.0k 3.1×	100	11.9k
Martha R. Stampfer United States	54	6.0k 0.8×	3.7k 0.8×	881 0.5×	1.8k 1.6×	1.5k 1.5×	132	9.4k

Countries citing papers authored by Emma Lees

Since Specialization

Citations

This map shows the geographic impact of Emma Lees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Lees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Lees more than expected).

Fields of papers citing papers by Emma Lees

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Lees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Lees. The network helps show where Emma Lees may publish in the future.

Co-authorship network of co-authors of Emma Lees

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Lees. A scholar is included among the top collaborators of Emma Lees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Lees. Emma Lees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lees, Emma & Ole W. Pedersen. (2025). Restoring the Regulated: The EU’s Nature Restoration Law. Journal of Environmental Law. 37(1). 75–96.

Lees, Emma & Ole W. Pedersen. (2024). Performative Environmental Law. Modern Law Review. 88(1). 124–154. 3 indexed citations

Lees, Emma, et al.. (2024). Fuzzy Universality in Climate Change Litigation. Transnational Environmental Law. 13(3). 502–521. 1 indexed citations

Roghanian, Ali, Guangan Hu, Christophe Fraser, et al.. (2019). Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression. Cancer Immunology Research. 7(11). 1876–1890. 29 indexed citations

Orozco, Olivia, Tinya J. Abrams, Jayesh Desai, et al.. (2018). Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies. Clinical Cancer Research. 24(14). 3465–3474. 18 indexed citations

Abrams, Tinya J., Xiaohong Niu, Millicent Embry, et al.. (2015). Abstract 1695: Development of a novel antibody-drug conjugate for the treatment of c-Kit expressing solid tumors and AML. Cancer Research. 75(15_Supplement). 1695–1695. 2 indexed citations

Menezes, Daniel L., Yan Tang, Jiajia Feng, et al.. (2014). A Synthetic Lethal Screen Reveals Enhanced Sensitivity to ATR Inhibitor Treatment in Mantle Cell Lymphoma with ATM Loss-of-Function. Molecular Cancer Research. 13(1). 120–129. 78 indexed citations

Parry, David, Timothy J. Guzi, Fergus Shanahan, et al.. (2010). Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor. Molecular Cancer Therapeutics. 9(8). 2344–2353. 434 indexed citations

Wang, Yaolin, Xiaoying Wang, Philip Lipari, et al.. (2008). SCH 727965, a novel cyclin-dependent kinase inhibitor, has potent anti-tumor acitivity in a wide-spectrum of human tumor xenograft models. Cancer Research. 68. 1594–1594. 1 indexed citations

10.

Parry, David, Timothy J. Guzi, Wolfgang Seghezzi, et al.. (2007). In vitro and in vivo characterization of SCH727965 a novel potent cyclin dependent kinase inhibitor. Cancer Research. 67. 4371–4371. 3 indexed citations

11.

Shanahan, Fergus, et al.. (2003). Role for BRG1 in Cell Cycle Control and Tumor Suppression. Molecular and Cellular Biology. 24(1). 362–376. 137 indexed citations

12.

O’Farrell, Anne-Marie, David Parry, Frédérique Zindy, et al.. (2000). Stat3-Dependent Induction of p19INK4D by IL-10 Contributes to Inhibition of Macrophage Proliferation. The Journal of Immunology. 164(9). 4607–4615. 57 indexed citations

13.

Shanahan, Fergus, Wolfgang Seghezzi, David Parry, Daniel Mahony, & Emma Lees. (1999). Cyclin E Associates with BAF155 and BRG1, Components of the Mammalian SWI-SNF Complex, and Alters the Ability of BRG1 To Induce Growth Arrest. Molecular and Cellular Biology. 19(2). 1460–1469. 140 indexed citations

14.

Cho, Helen, George M. Orphanides, Xiaoqing Sun, et al.. (1998). A Human RNA Polymerase II Complex Containing Factors That Modify Chromatin Structure. Molecular and Cellular Biology. 18(9). 5355–5363. 245 indexed citations

15.

Mahony, Daniel, David Parry, & Emma Lees. (1998). Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene. 16(5). 603–611. 83 indexed citations

16.

Maldonado, Edio, Ramin Shiekhattar, Michael Sheldon, et al.. (1996). A Human RNA-Polymerase-II Complex-Associated with SRB and DNA-Repair Proteins (Vol 381, Pg 86, 1996). Nature. 384(6607). 384–384. 2 indexed citations

17.

Solvason, Nanette, Wei Wu, Nisha H. Kabra, et al.. (1996). Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.. The Journal of Experimental Medicine. 184(2). 407–417. 95 indexed citations

18.

Walker, RA, et al.. (1996). Breast carcinomas occurring in young women (< 35 years) are different. British Journal of Cancer. 74(11). 1796–1800. 174 indexed citations

19.

Lees, Emma & Ed Harlow. (1993). Sequences Within the Conserved Cyclin Box of Human Cyclin A are Sufficient for Binding to and Activation of cdc2 Kinase. Molecular and Cellular Biology. 13(2). 1194–1201. 45 indexed citations

20.

Koff, Andrew, et al.. (1992). Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Trends in Cell Biology. 2(12). 362–362. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact